Identification of dopamine receptor in Tetrahymena thermophila by fluorescent ligands.Dopamine D1 receptor activation improves PCP-induced performance disruption in the 5C-CPT by reducing inappropriate responding.Dopamine receptors participate in acquisition and consolidation of latent learning of spatial information in zebrafish (Danio rerio).Modulatory effects of dopamine receptors on associative learning performance in zebrafish (Danio rerio).The dopamine D1 receptor agonist SKF 38393 improves temporal order memory performance in maternally deprived rats.D₁ receptor activation improves vigilance in rats as measured by the 5-choice continuous performance test.Effects of dopamine agonists on calling behavior in the green tree frog, Hyla cinerea.Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.The influence of dopaminergic system in medial prefrontal cortex on ketamine-induced amnesia in passive avoidance task in mice.D1-like antagonist blocks conditioned place preference induced by ejaculation in male rats.SKF 38393 reverses cocaine-conditioned place preference in mice.The selective inhibition of the D₁ dopamine receptor results in an increase of metabolized dopamine in the rat striatum.Frequency-Dependent Modulation of Dopamine Release by Nicotine and Dopamine D1 Receptor Ligands: An In Vitro Fast Cyclic Voltammetry Study in Rat Striatum.[Stimulation of D1-receptors improves passive avoidance learning of female rats during ovary cycle].Trans-activation of TRPV1 by D1R in mouse dorsal root ganglion neurons.[Administration of quinpirole with 17beta-estradiol in low doses corrects active avoidance performance in ovariectomized female rats].Effects of dopamine D1 receptor activation and blockade on dopamine and noradrenaline levels in the rat brain.SKF 38393: vacillatory behavior in immature ratsEffect of antidepressant drugs and different receptor antagonists on the grooming induced by the dopamine D-1 agonist SKF 38393[Synergetic activation of the nucleus accumbens nirtergic system by dopamine D1 and D2 receptor agonists]
P921
Q35049704-4E6EA7F1-14DA-4436-A750-3BC417B7152CQ36618769-85AC8614-B141-43D9-8BE0-9D1ED8A9B625Q38920249-D551485B-0208-468C-9BDE-EF10672A1A1DQ40071315-0E3733F1-C717-4114-9836-5296B1490414Q44110644-F45AEB11-A406-4FA7-B11B-17465F7EF0A4Q44543014-1D5FA7BD-94D2-4DE4-8F12-B1D9D94F026DQ44637317-789A3AED-F586-4BBF-9908-60E66F7249CBQ46944863-0394660A-55D4-4CB2-9E45-F6D8145ABADEQ47445294-F6B584A7-BA4A-46C4-B524-D6CB4F542B2DQ47775510-2B066F3A-1C2A-417D-847D-7BF7D3C6B3DDQ48182016-590A416F-E279-44D5-A2FF-45BDF764A7B2Q48521627-C398A34A-D7DB-418A-95B1-0024A1B0BE38Q48832474-0C09D8B0-207A-41D5-8804-0D1362547D34Q50801451-49756C70-F9F4-4241-AC4A-C4321656D3A0Q51791025-3EEAAD09-0042-4A01-AD83-9D8CCBF776BFQ51831059-06F3481B-4B87-4B62-95B3-5CE3FD677571Q52145451-71FC454F-531C-462A-943A-50A316FFCE4AQ69370001-465F00CB-283E-447C-B303-2ED9FB9D479AQ69379498-2D126549-6273-41E5-90FC-043E6F0248F5Q85210624-A2DA2F98-9DD7-406A-A27B-E335A1192279
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
SKF-38393
@en
SKF-38393
@sh
SKF-38393
@sr
أس كي أف-38,393
@ar
type
label
SKF-38393
@en
SKF-38393
@sh
SKF-38393
@sr
أس كي أف-38,393
@ar
altLabel
C16H17N1O2
@sr
C16H17NO2
@sr
R(+)SKF38393
@en
SKF 38393
@en
SKF-38,393
@en
SKF-38,393
@sr
SKF38393
@en
أس كي أف-٣٨,٣٩٣
@ar
prefLabel
SKF-38393
@en
SKF-38393
@sh
SKF-38393
@sr
أس كي أف-38,393
@ar
P486
P592
P6366
P661
P662
P683
P2067
255.125929
P231
67287-49-4
P233
C1CNCC(C2=CC(=C(C=C21)O)O)C3=CC=CC=C3
P234
1S/C16H17NO2/c18-15-8-12-6-7-1 ...... 11/h1-5,8-9,14,17-19H,6-7,10H2
P235
JUDKOGFHZYMDMF-UHFFFAOYSA-N
P274
P2868
P3117
DTXSID10894836
P486
P592
CHEMBL286080
P6366
2779219559